Company / Operating Income
Insulet Corporation Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$473.8M
FY2025
5-year range
$50.0M / $473.8M
FY2021-FY2025
Trend
+53.4%
vs FY2024
Sector context
#43 of 156
Health Care
What the data says
At $474M, Insulet Corporation's operating income ranks #43 of 156 in the Health Care sector. Operating Income has increased for 6 consecutive years, from -$7M in FY2019 to $474M in FY2025.
Based on SEC 10-K filings.
$474M in FY2025 with a 5-year CAGR of +76.8%.
Improved from $220M to $474M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +109.5%
- 5-Year CAGR
- +76.8%
- 10-Year CAGR
- -
Sector benchmark
#43 of 156 in Health CareTop 28% of 156This company $473.8M Sector average $733.1M
▼
-35.4% below sector average
Key checks
Key Insights
- Insulet Corporation's operating income has grown for 6 consecutive years.
- 5-year CAGR of +76.8%, indicating consistent growth.
- In FY2025, operating income increased 53.4% year-over-year.
- Ranks #43 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $473.8M | +53.4% |
| FY2024 | $308.9M | +40.3% |
| FY2023 | $220.1M | +327.4% |
| FY2022 | $51.5M | +3.0% |
| FY2021 | $50.0M | +82.5% |
| FY2020 | $27.4M | +470.3% |
| FY2019 | -$7.4M | -127.0% |
| FY2018 | $27.4M | +470.3% |
| FY2017 | -$7.4M | +30.9% |
| FY2016 | -$10.7M | +78.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026